Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication

Publisher： Karger

E-ISSN： 1423-0232|92|1|40-49

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.1, 2016-10, pp. : 40-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2150-2157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 154-166

Karger

Access to resources Recommend Favorite

Sorafenib Decreases Extrahepatic Collaterals in Hepatocellular Carcinoma: Implication of the Synergistic Effect of Sorafenib and Transcatheter Chemoembolization

By  

Current Medical Imaging Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 191-193

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?

By Hucke Florian  

Wiener klinische Wochenschrift, Vol. 123, Iss. 17-18, 2011-09 ,pp. : 542-551

Springer Publishing Company

Access to resources Recommend Favorite

Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2203-2217

John Wiley & Sons Inc

Access to resources Recommend Favorite